RK
Ram Kumar Keshari
About Ram Kumar Keshari
Data last updated:
Ram Kumar Keshari is a Director at Amarzone Pharma Private Limited (since 2021). The companies operate in Pharma. Amarzone Pharma Private Limited reported revenue of ₹8.85 Cr (FY 2025). Earlier, Ram Kumar Keshari was a Director at Aimcad Biotech Private Limited (2017–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Amarzone Pharma Private Limited U24236UP2021PTC153555 | Director | 08 Oct 2021 | 2021 | ₹8.85 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aimcad Biotech Private Limited U74120MH2013PTC272456 | Director | 27 Dec 2017 | 2013 | ₹4.69 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ram Kumar Keshari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shyam Kumar Keshari | 05145193 | Amarzone Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ram Kumar Keshari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ram Kumar Keshari
Ram Kumar Keshari currently holds 1 directorship: Amarzone Pharma Private Limited (Director, since 08 Oct 2021, revenue ₹8.85 Cr (FY 2025)).
Ram Kumar Keshari was first appointed on 27 Dec 2017 as Director at Aimcad Biotech Private Limited. The most recent appointment on record is 08 Oct 2021 at Amarzone Pharma Private Limited.
Ram Kumar Keshari held 1 earlier board appointment: Aimcad Biotech Private Limited (Director, 27 Dec 2017 to 25 Feb 2021).
The current boards of Ram Kumar Keshari's companies include Shyam Kumar Keshari (Amarzone Pharma Private Limited).